Item 2.02. Results of Operations and Financial Condition.
In connection with the press release described in Item 8.01 below, on January 6,
2020, Eiger BioPharmaceuticals, Inc. (the "Company") announced that on a
preliminary and unaudited basis, it estimates that it had approximately
$95 million in cash, cash equivalents and investments as of December 31, 2019.
The estimate is a preliminary estimate based on currently available information
and does not present all necessary information for a complete understanding of
the Company's financial condition as of December 31, 2019 or the Company's
results of operations for the year ended December 31, 2019.
The information in this item 2.02 shall not be deemed to be "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section 11 and 12(a)(2) of the Securities Act
of 1933, as amended. The information in this item 2.02 shall not be incorporated
by reference into any filing with the U.S. Securities and Exchange Commission
made by Eiger BioPharmaceuticals, Inc., whether made before or after the date
hereof, regardless of any general incorporation language in such filing.
Item 8.01. Other Events.
On January 6, 2020, the Company issued a press release titled "Eiger Updates on
2019 Progress and 2020 Milestones Expected." A copy of the press release is
attached hereto as Exhibit 99.1 and incorporated herein by reference.
Forward-Looking Statements
Statements in this report that are not strictly historical in nature constitute
"forward-looking statements." Such statements include, but are not limited to
the cash, cash equivalents and investments as of December 31, 2019. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors. More information about the risks the Company faces is included
under the headings "Risk Factors" in the Company's most recently filed documents
with the U.S. Securities and Exchange Commission. The Company is providing this
information as of this date and does not undertake any obligation to update any
forward-looking statements contained in this report as a result of new
information, future events or otherwise.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press release, dated January 6, 2020, titled "Eiger Updates on 2019
Progress and 2020 Milestones Expected."
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses